CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in NSCLC. (April 2023) - Horne, Ashley; Brown, Sarah; Coyle, Vicky; Franks, Kevin; Hassani, Adam; Harrow, Stephen; Hatton, Matthew; Hiley, Crispin; Kendall, Jessica; Oughton, Jamie; Shaw, Paul; Walker, Fiona; et al.